Insider filing · CNTA

Saurabh Saha sold $929K of Centessa Pharmaceuticals (CNTA)

Executed Nov 20 2024, disclosed Nov 22 2024, 2 days later.

Returns are measured on stock purchases only.

SS Saurabh Saha Director profile →

Saurabh Saha (Director) filed 13 Form 4 reports in the past 24 months (1 purchase, 12 sales), most often in Centessa Pharmaceuticals plc (CNTA). Across 1 priced purchase filing, the average 21-session return was -8.8% from execution and -3.4% from disclosure (delay-adjusted; derived). The largest single filing was $1.6M of CNTA (87,496 sh × $18.46, as filed), executed Dec 6 2024.

CNTA Centessa Pharmaceuticals plc CNTA · Healthcare · 56 filings in 24 months ticker →

Healthcare · Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in t…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→